Psychological and Psychiatric Issues in Functional Constipation, Fecal Incontinence and Bladder and Bowel

Alexander von Gontard1, Anka Nieuwhof-Leppink2, Ubirajara Barroso3

  • 1Governor Kremers Center, Department of Urology, Maastricht University Medical Center, Maastricht, The Netherlands.

Insights

Psychological and psychiatric issues are common in children with fecal incontinence (FI), functional constipation (FC), and bladder and bowel dysfunction (BBD). Early screening and assessment are crucial for effective management and improved outcomes.

Area of Science:

  • Pediatric gastroenterology
  • Child psychiatry
  • Behavioral science

Background:

  • Psychological and psychiatric aspects of pediatric functional bowel and bladder disorders are complex.
  • Subclinical psychological symptoms and clinical behavioral disorders are frequently observed.

Purpose of the Study:

  • To provide an updated overview of psychological and psychiatric aspects of fecal incontinence (FI), functional constipation (FC), non-retentive FI (NRFI), and bladder and bowel dysfunction (BBD).
  • To outline screening, assessment, counseling, and treatment recommendations.

Main Methods:

  • Review of relevant publications on psychological and psychiatric aspects.
  • Consensus-finding process among International Children's Continence Society (ICCS) board members.

Main Results:

  • High rates of comorbid psychiatric disorders (30%-50%) in children with FI, FC, and NRFI.
  • Children with BBD are a special risk group.
  • Associated psychiatric disturbances include externalizing, internalizing, and neurodevelopmental disorders, negatively impacting compliance and outcomes if untreated.

Conclusions:

  • Screening for psychological symptoms is recommended for all children with FI, FC, NRFI, and BBD.
  • Validated broadband behavioral questionnaires are recommended alongside clinical assessment.
  • Full child psychiatric or psychological assessment is advised for children with clinically significant problems.
Abstract

Related Concept Videos

Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
19
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
983
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
887